These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4332362)

  • 1. [Aggregating action of phospholipase C of Clostridium welchii on human platelets].
    Chap H; Lloveras J; Douste-Blazy L
    C R Acad Hebd Seances Acad Sci D; 1971 Oct; 273(16):1452-5. PubMed ID: 4332362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phospholipase C-induced release reaction in platelets (author's transl)].
    Chap H; Douste-Blazy L
    Eur J Biochem; 1974 Oct; 48(2):351-5. PubMed ID: 4375036
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation of prothrombinase activity of platelets and erythrocytes by sub-lytic treatment with phospholipase C from Clostridium welchii.
    Comfurius P; Bevers EM; Zwaal RF
    Biochem Biophys Res Commun; 1983 Dec; 117(3):803-8. PubMed ID: 6320817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase.
    Mauco G; Chap H; Simon MF; Douste-Blazy L
    Biochimie; 1978 Sep; 60(6-7):653-61. PubMed ID: 214164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of heparin on platelets.
    De Gaetano G; Vermylen J
    Lancet; 1972 Aug; 2(7773):376-7. PubMed ID: 4114737
    [No Abstract]   [Full Text] [Related]  

  • 6. Density gradient separation of human platelets from plasma and the role of plasma in adenosine diphosphate induced platelet electrophoretic mobility changes.
    Nicholls DG; Hampton JR
    Thromb Diath Haemorrh; 1972 Jul; 27(3):425-33. PubMed ID: 4662609
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet aggregation inhibitors. 4. N 6 -substituted adenosines.
    Kikugawa K; Iizuka K; Ichino M
    J Med Chem; 1973 Apr; 16(4):358-64. PubMed ID: 4716180
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and contact activation of blood clotting. Influence of some aggregation inhibitors.
    Coccheri S; Alessandri M; De Rosa V
    Acta Med Scand Suppl; 1971; 525():253-6. PubMed ID: 5292097
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggregation of platelets in the mesenteric microcirculation of the rat induced by alpha-toxin (phospholipase C) of Clostridium perfringens.
    Ohsaka A; Tsuchiya M; Oshio C; Miyairi M; Suzuki K; Yamakawa Y
    Toxicon; 1978; 16(4):333-41. PubMed ID: 210536
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of platelet membrane phospholipids in the platelet release reaction.
    Schick PK; Yu BP
    J Clin Invest; 1974 Nov; 54(5):1032-9. PubMed ID: 4371563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human platelet aggregation by a dibenzazepine compound (GP 44296) and by N-(2,6-dichlorophenyl)-o-aminophenylacetic acid (GP 45840).
    Jobin F; Gagnon FT
    Can J Physiol Pharmacol; 1971 May; 49(5):479-81. PubMed ID: 5120275
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine fibrinogen-induced platelet factor 3 and acid phosphatase availability in human platelets.
    Kubiaz P; Suranová J
    Scand J Haematol; 1973; 10(3):189-96. PubMed ID: 4203486
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of cyclic AMP in platelet function.
    Salzman EW; Weisenberger H
    Adv Cyclic Nucleotide Res; 1972; 1():231-47. PubMed ID: 4353170
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggregation of human red blood cells (RBC) and platelets and its reversal by a surface-active substance (Pluronic F68).
    Benner KU; Gaehtgens P; Frede KE
    Bibl Anat; 1973; 12():208-15. PubMed ID: 4790354
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandin E1 and platelets.
    Bousser MG
    Biomedicine; 1973 Mar; 18(2):95-102. PubMed ID: 4354464
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet shape change and aggregation.
    Caen JP; Michel H
    Nature; 1972 Nov; 240(5377):148-9. PubMed ID: 4629329
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of phospholipase C on human blood platelets.
    Otnaess AB; Holm T
    J Clin Invest; 1976 Jun; 57(6):1419-25. PubMed ID: 819457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.